Earlier on July 17, Sharmin Mossavar-Rahmani, Goldman Sachs CIO of wealth management, joined ‘Squawk Box’ on CNBC to discuss the latest market trends, what to expect in H2 2025, the state of the economy, impact of tariffs, and more. She expects earnings to continue to surprise to the upside. Mossavar-Rahmani noted that while only 8% of companies have reported so far, the consensus earnings estimates are too low, as they project a slight decrease in EPS, which is an event that occurs very rarely. She added that even during recessions, EPS typically increases sequentially. She argued that this pessimism sets a low bar, which is generally positive for the stock market.

Mossavar-Rahmani also confirmed that growth expectations have been downgraded from over 2% to around 1.5%, so the slowdown, expected in H2, is priced into the market. She doesn’t see a 1.5% growth rate as a problem, but rather a positive that will lead to less inflationary pressure. She likened the current situation with tariffs to the debate over whether COVID-related inflation was transitory or persistent. She explained that it takes time to separate the noise from the economic data. She noted that the average tariff rate started the year at about 2.5% but has risen to around 14%, with an expectation to end up between 15% and 20%. She stated that Goldman Sachs’s research suggests that the cost of these tariffs will be distributed: 20% absorbed by producers, 40% by US businesses, and 40% by consumers, which is a number that could eventually reach 70% for consumers, thereby creating some inflation.

That being said, we’re here with a list of the 11 best upside stocks to invest in now.

Our Methodology

We first sifted through different stock screeners to compile a list of the best stocks with analysts’ upside potential of over 35%, as of August 11. We then selected the 11 stocks that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q1 2025.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

11 Best Upside Stocks to Invest in Now

11. HubSpot Inc. (NYSE:HUBS)

Average Upside Potential as of August 11: 60.77%

Number of Hedge Fund Holders: 61

HubSpot Inc. (NYSE:HUBS) is one of the best upside stocks to invest in now. On August 7, FormAssembly, which is a data collection platform, announced the release of its new HubSpot Connector. The integration allows HubSpot users to build dynamic and secure web forms and directly route collected data into the HubSpot CRM.

The connector is designed to simplify complex data workflows, improve lead capture, and increase data accuracy by automating the flow of information. It offers real-time integration with both standard and custom objects within HubSpot, as well as advanced routing capabilities. FormAssembly’s expertise in secure and scalable data capture is now extended to the HubSpot ecosystem to make compliant data collection more accessible across different platforms.

The forms can be created using a drag-and-drop tool and can be multi-page, branded, and equipped with features like conditional logic, pre-fill, and save and resume functionality. Responses can be routed to multiple destinations, including HubSpot, and can trigger other workflows upon submission. The connector is versatile and can support various use cases in marketing, sales, and support.

HubSpot Inc. (NYSE:HUBS) provides a cloud-based customer relationship management/CRM platform for businesses in the Americas, Europe, and the Asia Pacific. The company’s CRM platform includes Marketing Hub, Sales Hub, Service Hub, and Content Hub.

10. Revolution Medicines Inc. (NASDAQ:RVMD)

Average Upside Potential as of August 11: 107.49%

Number of Hedge Fund Holders: 61

Revolution Medicines Inc. (NASDAQ:RVMD) is one of the best upside stocks to invest in now. Earlier on July 23, Revolution Medicines announced that the US FDA granted Breakthrough Therapy Designation to elironrasib (RMC-6291), its RAS(-ON) G12C-selective inhibitor. The designation is for treating adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer/NSCLC who have already undergone chemotherapy and immunotherapy but have not yet been treated with a KRAS G12C inhibitor.

The designation aims to expedite the development and review of the drug, which addresses a significant unmet medical need. It was based on promising data from the Phase 1 RMC-6291-001 clinical trial. In the trial, elironrasib monotherapy showed competitive antitumor activity, a compelling objective response rate, and progression-free survival in patients with advanced KRAS G12C solid tumors.

Elironrasib is an innovative inhibitor that selectively binds to the oncogenic RAS(-ON) form of the RAS G12C variant. This variant is a driver in ~12% of NSCLC cases. Revolution Medicines is currently exploring elironrasib as a monotherapy and in combination with other treatments. KRAS mutations are found in nearly 30% of NSCLC cases, with KRAS G12C being the most common subtype. Currently, there are no fully FDA-approved RAS-targeted inhibitors for patients with KRAS G12C NSCLC.

Revolution Medicines Inc. (NASDAQ:RVMD) is a clinical-stage precision oncology company that develops novel targeted therapies for RAS-addicted cancers.

9. Caesars Entertainment Inc. (NASDAQ:CZR)

Average Upside Potential as of August 11: 79.17%

Number of Hedge Fund Holders: 63

Caesars Entertainment Inc. (NASDAQ:CZR) is one of the best upside stocks to invest in now. On August 4, Caesars Entertainment announced the debut of IGT’s new slot game, called Kitty Glitter Grand. This marked the first time IGT launched a new game simultaneously online and in physical casinos in the US. As a result, Caesars is the exclusive provider of this game, both digitally and on casino floors.

The game is available on the company’s online platforms, which include Caesars Palace Online Casino, Horseshoe Online Casino, and Caesars Sportsbook & Casino, in New Jersey, Pennsylvania, Michigan, West Virginia, and Ontario. In-person, the game can be played at Caesars Rewards destinations in Atlantic City, specifically Caesars and Harrah’s, with Tropicana to be added to the list pending regulatory approval

To celebrate the launch, Caesars is planning to host an exclusive VIP event for select Caesars Rewards members at Caesars Atlantic City in August. The company is also running an omnichannel promotion at its Atlantic City locations and a special leaderboard promotion on its digital platforms in all iGaming jurisdictions, excluding Ontario.

Caesars Entertainment Inc. (NASDAQ:CZR) is a gaming and hospitality company that owns, leases, brands, or manages domestic properties in 18 states with slot machines, video lottery terminals & e-tables, and hotel rooms, as well as table games, including poker.

8. Cytokinetics Incorporated (NASDAQ:CYTK)

Average Upside Potential as of August 11: 110.65%

Number of Hedge Fund Holders: 64

Cytokinetics Incorporated (NASDAQ:CYTK) is one of the best upside stocks to invest in now. On August 8, Citi lowered the firm’s price target on Cytokinetics to $77 from $80, while keeping a Buy rating on the shares. This sentiment followed the company’s Q2 2025 earnings report, which the firm views as uneventful.

In Q2, Cytokinetics reported a net loss of $134.4 million, or $1.12 per share, which was an improvement from the net loss of $143.3 million, or $1.31 per share, reported in Q2 2024. Cytokinetics ended the quarter with ~$1.04 billion in cash and investments, which was a decrease from the $1.09 billion reported at the end of Q1 2025.

In terms of clinical development, the FDA extended the PDUFA date for Aficamten to December 26, which may delay the drug’s approval and launch timeline. However, the company noted that all Good Clinical Practice/GCP inspections for Aficamten were completed with no negative observations, which is a positive sign for the regulatory process. The company is preparing for a late-cycle meeting with the FDA in September, which is scheduled to align with the PDUFA date extension.

Cytokinetics Incorporated (NASDAQ:CYTK) is a late-stage biopharmaceutical company that discovers, develops, and commercializes muscle activators and inhibitors as potential treatments for debilitating diseases in the US.

7. Monday.com Ltd. (NASDAQ:MNDY)

Average Upside Potential as of August 11: 99.56%

Number of Hedge Fund Holders: 64

Monday.com Ltd. (NASDAQ:MNDY) is one of the best upside stocks to invest in now. On August 12, Jefferies analyst Brent Thill lowered the firm’s price target on Monday.com to $330 from $360, while keeping a Buy rating on the shares. Although the company’s Q2 2025 results were robust, the analyst’s sentiment was driven by the small FY25 revenue raise and AI fears.

Monday.com reported a strong 27% year-over-year revenue increase in Q2, which reached $299 million. The company’s non-GAAP operating income also grew to $45.1 million, up from $38.4 million in the same quarter of the previous year. Additionally, net cash from operating activities increased to $66.8 million from $55.8 million year-over-year.

Monday CRM product reached $100 million in Annual Recurring Revenue/ARR within 3 years of its launch. The company also introduced new AI-powered features, including Monday Magic, Monday Vibe, and Monday Sidekick. For Q3, Monday.com expects total revenue to be between $311 and $313 million, with a non-GAAP operating income projected to be between $34 and $36 million.

Monday.com Ltd. (NASDAQ:MNDY) develops software applications internationally. The company provides Work Operating System/OS, which is a cloud-based visual work OS that consists of modular building blocks used and assembled to create software applications and work management tools.

6. JD.com Inc. (NASDAQ:JD)

Average Upside Potential as of August 11: 35.11%

Number of Hedge Fund Holders: 66

JD.com Inc. (NASDAQ:JD) is one of the best upside stocks to invest in now. On July 30, JD.com announced a decision to make a voluntary public takeover offer for all shares of CECONOMY AG. CECONOMY is the parent company of European consumer electronics retailers MediaMarkt and Saturn. The offer is being made through a wholly-owned subsidiary, called JINGDONG Holding Germany GmbH (the Bidder), for a cash consideration of EUR 4.60 per share.

The Bidder and CECONOMY have signed an investment agreement related to the takeover offer and their future cooperation. The Bidder also has agreements with several CECONOMY shareholders, who have irrevocably committed to accept the offer for a total of 31.7% of the shares. This includes a 3.81% stake from CECONOMY’s largest shareholder group, Convergenta Invest GmbH.

Post-takeover, Convergenta will hold 25.35% of the CECONOMY shares. This secures a combined shareholding of 57.1% for JD.com’s future partners and the company itself before the offer’s launch. CECONOMY’s Supervisory Board and Management Board are in full support of the takeover. JD.com plans to contribute its advanced technology, e-commerce expertise, and logistics capabilities to strengthen CECONOMY’s business, which currently operates over 1,000 retail stores in 11 countries.

JD.com Inc. (NASDAQ:JD) is a supply chain-based technology and service provider in the People’s Republic of China. It operates through three segments: JD Retail, JD Logistics, and New Businesses.

5. Primo Brands Corporation (NYSE:PRMB)

Average Upside Potential as of August 11: 45.29%

Number of Hedge Fund Holders: 66

Primo Brands Corporation (NYSE:PRMB) is one of the best upside stocks to invest in now. On August 11, Morgan Stanley lowered the firm’s price target on Primo Brands to $35 from $38 with an Overweight rating on the shares. This decision followed the release of the company’s Q2 2025 earnings report.

In Q2, Primo Brands reported a 2.5% decline in net sales compared to the previous year. This was attributed to several factors, which included integration challenges in the direct delivery business that led to missed deliveries, a tornado that caused ~$26 million in lost net sales at a facility in Hawkins, Texas, and a $10 million sales reduction in the dispenser business due to tariff-related uncertainties.

The company still saw growth in its premium water segment, with net sales increasing by 44.2% year-over-year in Q2. This was driven by expanded distribution in key markets and retailers like Walmart for brands such as Saratoga and Mountain Valley. Primo Brands is also continuing its post-merger integration efforts, having closed 40 facilities in Q2, bringing the total to 48 closures, with 11 more planned.

Primo Brands Corporation (NYSE:PRMB) is a branded beverage company in North America. It offers solutions through water dispensers, direct delivery of refillable/reusable bottles, pre-filled Water exchange program, and water filtration appliances, as well as operates self-service water refill stations.

4. Antero Resources Corporation (NYSE:AR)

Average Upside Potential as of August 11: 41.98%

Number of Hedge Fund Holders: 67

Antero Resources Corporation (NYSE:AR) is one of the best upside stocks to invest in now. On July 31, Roth Capital analyst Leo Mariani lowered the firm’s price target on Antero Resources to $44 from $45, while maintaining a Buy rating on the shares. The firm increased earnings estimates after the company’s Q2 2025 earnings report but trimmed the price target to reflect weaker natural gas prices.

Antero Resources reported an average net production of 3.4 Bcfe/d, consisting of 2.2 Bcf/d of natural gas and 200 MBbl/d of liquids in Q2. The realized pre-hedge natural gas equivalent price was $3.85 per Mcfe, which was a $0.41 premium to NYMEX. However, the company’s realized natural gas price was negatively impacted by a $0.05 per Mcf discount to the benchmark index, caused by maintenance on a Gulf Coast pipeline in June.

Antero Resources achieved strong financial results, with a net income of $157 million and an adjusted net income of $110 million. The company generated $262 million in free cash flow, which it used to reduce its net debt by $187 million to a total of $1.1 billion. Additionally, Antero purchased 3.6 million shares for ~$126 million between April 1 and July 30.

Antero Resources Corporation (NYSE:AR) is an independent oil and natural gas company that develops, produces, explores, and acquires natural gas, natural gas liquids/NGLs, and oil properties in the US.

3. Fair Isaac Corporation (NYSE:FICO)

Average Upside Potential as of August 11: 47.38%

Number of Hedge Fund Holders: 68

Fair Isaac Corporation (NYSE:FICO) is one of the best upside stocks to invest in now. On July 31, Oppenheimer lowered the firm’s price target on Fair Isaac Corporation to $1,953 from $2,300 while keeping an Outperform rating on the shares. This sentiment by the firm followed the company’s FQ3 2025 financial results.

Fair Isaac Corporation reported a 20% year-over-year revenue increase, which reached $536.4 million. Net income for the quarter was $181.8 million, or $7.40 per share, which was a substantial increase from $126.3 million, or $5.05 per share, in the same period a year ago.

This performance was driven by the Scores segment, which saw its revenue grow by 34% to $324.3 million, which was fueled by a 42% increase in B2B revenue. B2C revenue also increased by 6%. The Software segment’s revenue growth was modest at 3%, and reached $212.1 million.

Fair Isaac Corporation (NYSE:FICO) develops software with analytics and digital decisioning technologies that enable businesses to automate, enhance, and connect decisions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

2. Chipotle Mexican Grill Inc. (NYSE:CMG)

Average Upside Potential as of August 11: 42.96%

Number of Hedge Fund Holders: 78

Chipotle Mexican Grill Inc. (NYSE:CMG) is one of the best upside stocks to invest in now. On August 12, Piper Sandler upgraded Chipotle to Overweight from Neutral with a price target of $50, down from $53. This decision followed the company’s Q2 2025 earnings report.

Chipotle Mexican Grill reported a total revenue of $3.1 billion in Q2, which was a 3% year-over-year increase driven by new restaurant openings. However, comparable sales declined by 4%, primarily due to a 4.9% decrease in transactions, which was partially offset by a 0.9% increase in the average check.

In Q2, the company opened 61 new restaurants, of which 47 included a Chipotlane, which brought the total number of locations to 3,839. Digital sales remain a strong point, accounting for 35.5% of total sales. The company maintains a strong balance sheet with $2.1 billion in cash and investments and no outstanding debt.

Chipotle Mexican Grill Inc. (NYSE:CMG) owns and operates Chipotle Mexican Grill restaurants. The company also provides delivery and related services through its app and website.

1. Eli Lilly and Company (NYSE:LLY)

Average Upside Potential as of August 11: 49.71%%

Number of Hedge Fund Holders: 119

Eli Lilly and Company (NYSE:LLY) is one of the best upside stocks to invest in now. On August 11, Eli Lilly announced its decision to use the confidential reimbursement price option in Germany for its Type 2 diabetes/T2D treatment, Mounjaro (tirzepatide). This marks the first time a company has taken advantage of this option since it was introduced at the beginning of 2025 under the Medical Research Act (Medizinforschungsgesetz, or MFG).

The negotiations for Mounjaro’s T2D reimbursement price between Lilly and the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) have already been concluded. The introduction of confidential pricing in Germany has been a source of controversy. The country has historically been a champion of price transparency, with discounted reimbursement prices for new therapies being publicly accessible.

The new policy was opposed because of the fear that it would lead to a rise in reimbursement costs. However, because of their lobbying, the final version of the MFG included an additional 9% discount on top of the negotiated discount for any company opting for confidential pricing, as well as a requirement to pay back overcharged surcharges and sales tax.

Eli Lilly and Company (NYSE:LLY) discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

While we acknowledge the potential of LLY to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LLY and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.